FLNA
Filana Therapeutics·NASDAQ
--
--(--)
--
--(--)
FLNA fundamentals
Filana Therapeutics (FLNA) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), beat estimates; EPS was -0.92 (YoY -807.69%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.92
-807.69%
Report date
Aug 14, 2025
Earnings Call
8:00 AM on Aug 14, 2025
Meeting link.EPS
Actual | -0.05 | -0.05 | -0.06 | -0.09 | -0.09 | -0.13 | -0.24 | -0.35 | -0.44 | -0.48 | -0.51 | -0.47 | -0.58 | -0.63 | -0.61 | -0.5 | -0.43 | 0.13 | -0.58 | -0.57 | -0.48 | -0.92 | ||||||||
Forecast | -0.06 | -0.0667 | -0.0475 | -0.085 | -0.128 | -0.15 | -0.335 | -0.415 | -0.4325 | -0.4775 | -0.56 | -0.555 | -0.59 | -0.775 | -0.52 | -0.46 | -0.4067 | -0.73 | -0.5833 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +16.67% | +10.04% | -89.47% | -5.88% | -1.56% | -60.00% | -4.48% | -6.02% | -10.98% | -6.81% | +16.07% | -4.50% | -6.78% | +21.29% | +3.85% | +6.52% | +131.96% | +20.55% | +2.28% | 0.00% | 0.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Filana Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Filana Therapeutics’s earnings call?What were the key takeaways from Filana Therapeutics's earnings call?What is the revenue and EPS growth rate for Filana Therapeutics year over year?What does Filana Therapeutics do and what are its main business segments?What is Filana Therapeutics's gross profit margin?Did Filana Therapeutics beat or miss consensus estimates last quarter?What guidance did Filana Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
